Dr. Ildegarda E. Scheidegger, Swiss Art-historian, is a strategic leader and former Sotheby's executive specializing in governance, high-level resource mobilization, and elite stakeholder management. With over 20 years navigating international partnerships and cultural institutions, she helps organizations engage effectively with decision-makers at the highest levels.

Dr. Renato Fassbind is a highly experienced Swiss financial expert and corporate leader, with a distinguished background as CFO of major global corporations and a strong reputation in corporate governance and board leadership. As a non-executive director, he has served on the boards of HSBC, Kühne+Nagel, Swiss Re, and others, and currently serves on the board of Nestlé.

Mikenda is an accomplished executive with a strong background in financial leadership, strategic management, and company establishment. As CFO at Mill Reef Capital, she guided the firm from start-up to operational excellence and previously made key contributions in private equity at Calibrium AG and Adveq Management AG.

Prof. Dr. med. Jean-Pierre Bourquin is Professor of Pediatric Oncology at the University of Zurich and Chief Physician of the Department of Hematology, Oncology, Immunology and Cellular Therapies at the University Children's Hospital Zurich. His research focuses on the transcriptional, epigenetic and post-transcriptional mechanisms of childhood leukemia and their translation into innovative therapies and precision medicine. Since 2026, he is Director of the Swiss National Competence Center for Research "Children & Cancer" funded by the Swiss National Science Foundation.

Prof. Dr med. Dr phil. Raffaele Renella is Associate Professor at the University of Lausanne (UNIL) and Head of the Pediatric Hematology-Oncology Unit at Lausanne University Hospital (CHUV). His research focuses on the molecular and cellular causes of pediatric cancers and blood disorders, in particular hematopoietic stem cell development, neuroblastoma, and gene and cell therapies. Since 2026, he is Co-Director of the Swiss National Competence Center for Research "Children & Cancer" funded by the Swiss National Science Foundation.

Prof. Dr. med. Stefan Pfister is Director of the Preclinical Research Program at the Hopp Children's Cancer Center Heidelberg (KiTZ) and heads the Division of Pediatric Neurooncology at the DKFZ. His research focuses on the genetic and epigenetic characterization of childhood brain tumors. He is a member of the National Academy of Sciences Leopoldina and recipient of the Gottfried Wilhelm Leibniz Award 2023 and the Ammann Award 2026.

Dr. med. Nikola Cihoric is Physician-entrepreneur and radiation oncologist with over 15 years at the intersection of clinical medicine and health technology. He is Founder of Wemedoo AG (Switzerland), where he built oomnia, a unified CDISC/FHIR-aligned clinical trial platform. He also serves as Senior Researcher at Insel Gruppe (University Hospital Bern).

Prof. Dr. Kimmo Porkka is Professor of Personalized Cancer Therapy at the University of Helsinki and Chief Physician at the Helsinki University Hospital Comprehensive Cancer Center. His research focuses on individualized therapy of relapsed cancer and computational tools for analyzing cancer and clinical data in federated networks. He co-leads the health data steering group of the European Hematology Association (EHA) and chairs the Finnish FinOMOP initiative.

Dr. Gudrun Schleiermacher, MD, PhD, is a physician-scientist at Institut Curie in Paris, where she leads the Translational Research in Pediatric Oncology team (RTOP). Her research focuses on the genetics of neuroblastoma, clonal evolution at relapse, and circulating tumor DNA as a biomarker in childhood cancers. She is co-PI of the national MAPPYACTS trial, leads the MICCHADO program on high-risk pediatric cancers, and holds leading roles in Europe's major pediatric oncology trial networks.